Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2003
11/25/2003US6653447 ULBP DNA and polypeptides
11/25/2003US6653445 Chemotactic cytokine V (CCV); isolated protein of given sequence; use in diagnostics and as anti-viral or anti-tumor agent
11/25/2003US6653444 Polypeptides comprising a B7 extracellular domain
11/25/2003US6653443 Viral infectivity factor protein (Vif) antagonist that binds to the multimerization domain within a Vif protein in a cell and inhibits Vif protein; treating acquired immunodeficiency syndrome (AIDS)
11/25/2003US6653292 Stimulating Th1 pattern of immune activation, cytokine production, NK lytic activity and B cell proliferation; modulating with nucleic acid sequences containing unmethylated CpG dinucleotides
11/25/2003US6653284 Keratinocyte growth factor-2 formulations
11/25/2003US6653283 Pharmaceutical compositions comprising troponin subunits, fragments and analogs thereof and methods of their use to inhibit angiogenesis
11/25/2003US6653282 Inhibit binding of leukocyte function- associated antigen (LFA-1) and intercellular adhesion molecule (ICAM); graft versus host disease, antiallergens, autoimmune diseases
11/25/2003US6653280 Antifungal polypeptide AlyAFP from Alyssum and methods for controlling plant pathogenic fungi
11/25/2003US6653134 Obtaining a bone marrow sample from a human, isolating stromal cells, and administering to the central nervous system of the patient; treating a genetic disease, a tumor, trauma and stroke
11/25/2003US6653132 IRES sequences with high translational efficiency and expression vectors containing the sequence
11/25/2003US6653128 Especially for rickettsial pathogen selected from the group consisting of Rickettsia spp., Ehrlichia spp., Anaplasma spp., and Cowdria
11/25/2003US6653127 Single-chain recombinant complexes of hepatitis C virus NS3 protease and NS4A cofactor peptide
11/25/2003US6653126 Isolated DNA, of given sequence, and RNA transcribed from it; mutant forms of drosophila gene
11/25/2003US6653125 Synthetic hepatitis C genes
11/25/2003US6653104 Immunotoxins, comprising an internalizing antibody, directed against malignant and normal cells
11/25/2003US6653103 For inhibiting export of nucleic acids from nucleus to cytoplasm of a cell
11/25/2003US6653102 Nucleotide sequence coding preferential protein for use in the treatment of nervous system disorders
11/25/2003US6653100 hKCa3/KCNN3 small conductance calcium activated potassium channel: A diagnostic marker and therapeutic target
11/25/2003US6653098 Transforming cell with an expression vector comprising an isolated polynucleotide; solubilizing the inclusion bodies; refolding and purifying; urea, dithiothreitol and cysteine; angiogenesis inhibitors; anticarcinogenic agents
11/25/2003US6653097 Human calcium channel compositions and methods
11/25/2003US6653088 Ligands; incubating mixture; labeling with fluorophore; spectrofluorometry at emission wavelengths; use in treatment of Alzheimer's disease
11/25/2003US6653086 Fusion protein; ligand has not been identified; screening for agonists/ antagonists
11/25/2003US6653085 Extracted from human placenta cell; contacting with sera and allowing it to complex with antibodies; use for diagnosing intestinal malabsorption diseases
11/25/2003US6653084 Anti-erbB-2 antibodies to human receptor related to but distinct from EGF receptor
11/25/2003US6653074 Methods for identifying agents which affect cellular morphology, locomotion and death
11/25/2003US6653072 Improving expression of a protein encoded by DNA substrate by assembling oligonucleotides into recombinant nucleic acids and using it to transform cells; recursive sequence recombination
11/25/2003US6653071 Dissecting the regulatory circuitry of a eukaryotic genomei
11/25/2003US6653064 Method for identifying compounds useful in the therapy of bone disorders
11/25/2003US6652885 Complexing drug with diketopiperazine; washing; separation of impurities
11/25/2003US6652863 Creating fusion compounds by linking to auto-antigenic sequences
11/25/2003US6652862 Biologically active bactericidal/permeability-increasing protein fragments
11/25/2003US6652861 No cytotoxic ribosome inactivation, no affect on fertility of sperm
11/25/2003US6652860 Peptide, apoEp 1.B, compositions and uses thereof
11/25/2003US6652859 Diagnosis and therapy
11/25/2003US6652858 Administering an OX-2 protein or a nucleic acid encoding it to preventing graft rejection, fetal loss, autoimmune disease, and allergies; immunosuppressants; gene therapy
11/25/2003US6652857 Methods for producing avian verotoxin antitoxin
11/25/2003US6652850 Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity
11/25/2003CA2100860C A receptor tyrosine kinase target protein cdna cloning method and hgrb proteins
11/25/2003CA2086888C Whooping cough vaccine
11/25/2003CA2074166C Method for treating intestinal diseases
11/25/2003CA1341448C Vector comprising a sequence coding for an aminoacid sequence found in a mammalian protein with g-protein-ligand membrane receptor activity
11/20/2003WO2003096025A1 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 4 (gpr4)
11/20/2003WO2003096024A1 Diagnostics and therapeutics for diseases associated with vasoactive intestinal peptide receptor 2 (vpac2)
11/20/2003WO2003096022A2 Screening for peptides inhibiting pp1c binding to bcl-2, bcl-xl and bcl-w proteins
11/20/2003WO2003096017A1 Methods and compositions for inducing an immune response
11/20/2003WO2003095976A2 Qm-7 and qt-6 cells transfected with mutant cell surface expressed channel receptors and assays using the transfected cells
11/20/2003WO2003095968A2 Method for simultaneously detecting an antigen and an antibody of an infectious microorganism
11/20/2003WO2003095678A1 Ldl receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions
11/20/2003WO2003095671A1 Method of diagnosis and treatment for affective disorders
11/20/2003WO2003095667A2 Autoimmune conditions and nadph oxidase defects
11/20/2003WO2003095663A2 Modified t lymphocytes and uses therefor
11/20/2003WO2003095654A2 Method for producing a transgenic plant having modified transport of substances
11/20/2003WO2003095653A1 Promoters having a modified transcription efficiency and derived from methyltrophic yeast
11/20/2003WO2003095644A1 Novel proteins and dnas thereof
11/20/2003WO2003095642A2 Polyepitopes and mini-genes for cancer treatment
11/20/2003WO2003095641A1 Intracellular protein delivery compositions and methods of use
11/20/2003WO2003095640A2 Transgenic rat as animal model for human huntingdon's disease
11/20/2003WO2003095623A2 Genetically engineered cell lines and systems for propagating varicella zoster virus and methods of use thereof
11/20/2003WO2003095622A2 Proteins associated with cell growth, differentiation, and death
11/20/2003WO2003095614A2 Cytokine polypeptides
11/20/2003WO2003095613A2 Nucleic acids, polypeptides, and methods for modulating apoptosis
11/20/2003WO2003095611A2 Androgen-regulated pmepa1 and cancer
11/20/2003WO2003095610A2 Directed evolution method of generating enhanced folding polypeptide variants
11/20/2003WO2003095607A2 Role of p62 in aging-related disease
11/20/2003WO2003095605A2 A chimeric reverse transcriptase and methods for identifying telomerase inhibitors
11/20/2003WO2003095604A2 Purified peptide deformylase from streptococcus pneumoniae
11/20/2003WO2003095493A2 Toxin-related antibodies with antimicrobial and antiviral activity
11/20/2003WO2003095489A1 Hexamers of receptors, members of the tnf receptor family, their use in therapy and pharmaceutical compositions comprising the same
11/20/2003WO2003095488A1 Chimeric antagonist anth1
11/20/2003WO2003095487A2 Immunogenic cd1 complexes
11/20/2003WO2003095486A1 Use of a peptide derived from the beta-subunit of hcg in order to generate an anti-tumour ctl-type response
11/20/2003WO2003095485A2 Krib polynucleotides and polypeptides and uses thereof in the treatment of metabolic disorders
11/20/2003WO2003095484A2 Polypeptides increasing p53 expression
11/20/2003WO2003095483A1 Dna encoding for a gtpase activating protein
11/20/2003WO2003095482A2 Novel cyclic peptides and use thereof as anti-microbial agents
11/20/2003WO2003095481A1 Streptococcal superantigens spe-l and spe-m
11/20/2003WO2003095480A2 Brachyspira hyodysenteriae vaccine
11/20/2003WO2003095479A1 Multiple branch peptide constructions comprising from 2 to 16 branches of the peptide rqgys or from 8 to 16 branches of the peptide rqgy providing from the hiv gp41 glycoprotein
11/20/2003WO2003095477A2 Miniprotein ligands and other polypeptides and methods for making and using same
11/20/2003WO2003095475A2 Peptide compounds and their use as protease substrates
11/20/2003WO2003095473A2 Peptides and methods for cell death regulation
11/20/2003WO2003094973A1 Agent and method for transporting biologically active molecules in cells
11/20/2003WO2003094961A1 Improved polysaccharide and glycoconjugate vaccines_____________
11/20/2003WO2003094959A1 Improved polysaccharide and glycoconjugate vaccines
11/20/2003WO2003094951A1 Soluble formulations comprising insulin aspart and insulin detemir
11/20/2003WO2003094949A1 Mammalian genes modulated during fasting and feeding
11/20/2003WO2003094862A2 tRNA SYNTHASE: MODULATORS OF ANGIOGENESIS
11/20/2003WO2003094860A2 Use of homo sapiens chromosome 1 open reading frame 28 (c1orf28) in the diagnosis of hyperparathyroidism-jaw tumor syndrome
11/20/2003WO2003094858A2 Ctp-extended erythropoietin
11/20/2003WO2003094849A2 Ferritin fusion proteins for use in vaccines and other applications
11/20/2003WO2003094848A2 Nucleic acid-associated proteins
11/20/2003WO2003094844A2 Prostate cancer-related compositions, methods, and kits based on dna macroarray proteomics platforms
11/20/2003WO2003094843A2 Cell adhesion and extracellular matrix proteins
11/20/2003WO2003094835A2 Fgf variants and methods for use thereof
11/20/2003WO2003094610A1 Research models for the evaluation of retinopathy or microangiopathy and uses thereof
11/20/2003WO2003081996A3 Non-human transgenic mammals carrying germile mutations in both the p53 andfos genes and their use as a disease model
11/20/2003WO2003074546A8 Streptavidin-binding peptide
11/20/2003WO2003070192A9 Compositions and methods for surrogate antibody modulation of an immune response and transport
11/20/2003WO2003066849A3 Novel purified polypeptides from staphylococcus aureus
1 ... 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 ... 2916